<- Go Home
Nephros, Inc.
Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. It also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, bacteria, cysts, particulates, heavy metals, chemical compounds, scale build-up in downstream equipment, and other various contaminants. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
Market Cap
$46.8M
Volume
26.5K
Cash and Equivalents
$5.2M
EBITDA
$1.6M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$11.3M
Profit Margin
63.24%
52 Week High
$5.98
52 Week Low
$1.39
Dividend
N/A
Price / Book Value
4.67
Price / Earnings
31.69
Price / Tangible Book Value
5.35
Enterprise Value
$42.7M
Enterprise Value / EBITDA
20.76
Operating Income
$1.4M
Return on Equity
16.29%
Return on Assets
7.64
Cash and Short Term Investments
$5.2M
Debt
$1.2M
Equity
$10.0M
Revenue
$17.9M
Unlevered FCF
$2.1M
Sector
Machinery
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium